Status: Recruiting
Study of ENP-501 in Peanut-Allergic and Non-Allergic Participants
This is a Phase 1/2 study to evaluate the safety and clinical activity of ENP-501 in non-peanut allergic (NPA) healthy participants and participants with an established peanut allergy (PA)
Participants needed: 68
Trial details
Phase: Phase 1, Phase 2Age: 14-50Biological sex: AllType: InterventionalSponsor: N-Fold, LLCUpdated: Apr 24, 2026Locations: 1
Eligibility criteria
14-50 years of age (inclusive) [+24]
History of severe anaphylactic event requiring mechanical ventilation or use of... [+18]